SEOUL, South Korea--(BUSINESS WIRE)--The personalized medicine and biotechnology company, Macrogen (CEO Hyonyong Chong, www.macrogen.com) (KOSDAQ:038290) has announced that the company has entered into a genome analysis service provision agreement with University College London (UCL, www.ucl.ac.uk) continuing from last year.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
